Aránzazu Alfaro Sáez

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Eslicarbazepine acetate (ESL, Aptiom™) is a once-daily anticonvulsant, approved as adjunctive treatment of partial-onset seizures (POS). Historical-controlled trials investigating the use of ESL as monotherapy have demonstrated a favorable efficacy and tolerability profile in patients with POS. This prospective, non-interventional study recruited POS(More)
  • 1